04/28/2025
5:27 PM | Clyburn Frank (Reporting)
Revolution Medicines, Inc. (Issuer)
Revolution Medicines (Issuer)
| Form 4/A | |
03/24/2025
3:55 PM | Cislini Jeff (Reporting)
Revolution Medicines, Inc. (Issuer)
Revolution Medicines (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/20/2025
3:32 PM | Cislini Jeff (Reporting)
Revolution Medicines, Inc. (Subject)
Revolution Medicines (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/19/2025
4:40 PM | Revolution Medicines, Inc. (Issuer)
Revolution Medicines (Issuer)
Wang Xiaolin (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/19/2025
4:40 PM | Kelsey Stephen Michael (Reporting)
Revolution Medicines, Inc. (Issuer)
Revolution Medicines (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/19/2025
4:41 PM | Horn Margaret A (Reporting)
Revolution Medicines, Inc. (Issuer)
Revolution Medicines (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/19/2025
4:42 PM | Anders Jack (Reporting)
Revolution Medicines, Inc. (Issuer)
Revolution Medicines (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/19/2025
4:43 PM | GOLDSMITH MARK A (Reporting)
Revolution Medicines, Inc. (Issuer)
Revolution Medicines (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/19/2025
4:43 PM | Cislini Jeff (Reporting)
Revolution Medicines, Inc. (Issuer)
Revolution Medicines (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/14/2025
4:42 PM | Anders Jack (Reporting)
Revolution Medicines, Inc. (Subject)
Revolution Medicines (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/14/2025
4:14 PM | Cislini Jeff (Reporting)
Revolution Medicines, Inc. (Subject)
Revolution Medicines (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
Get the Latest News and Ratings for RVMDW and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Revolution Medicines and its competitors with MarketBeat's FREE daily newsletter. |
03/14/2025
3:47 PM | Kelsey Stephen Michael (Reporting)
Revolution Medicines, Inc. (Subject)
Revolution Medicines (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/14/2025
3:18 PM | Horn Margaret A (Reporting)
Revolution Medicines, Inc. (Subject)
Revolution Medicines (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/04/2025
6:02 PM | Anders Jack (Reporting)
Revolution Medicines, Inc. (Issuer)
Revolution Medicines (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/04/2025
6:03 PM | Cislini Jeff (Reporting)
Revolution Medicines, Inc. (Issuer)
Revolution Medicines (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/04/2025
6:00 PM | GOLDSMITH MARK A (Reporting)
Revolution Medicines, Inc. (Issuer)
Revolution Medicines (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/04/2025
6:01 PM | Revolution Medicines, Inc. (Issuer)
Revolution Medicines (Issuer)
Wang Xiaolin (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/04/2025
6:01 PM | Revolution Medicines, Inc. (Issuer)
Revolution Medicines (Issuer)
Wei Lin (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/04/2025
6:02 PM | Horn Margaret A (Reporting)
Revolution Medicines, Inc. (Issuer)
Revolution Medicines (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/04/2025
6:02 PM | Kelsey Stephen Michael (Reporting)
Revolution Medicines, Inc. (Issuer)
Revolution Medicines (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/26/2025
3:44 PM | Revolution Medicines, Inc. (Filer)
Revolution Medicines (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
02/26/2025
3:10 PM | Revolution Medicines, Inc. (Filer)
Revolution Medicines (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
02/14/2025
10:25 AM | JANUS HENDERSON GROUP PLC (Filed by)
Revolution Medicines, Inc. (Subject)
Revolution Medicines (Subject)
| Form SCHEDULE 13G | |
01/22/2025
4:30 PM | Cislini Jeff (Reporting)
Revolution Medicines, Inc. (Issuer)
Revolution Medicines (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/21/2025
3:20 PM | Cislini Jeff (Reporting)
Revolution Medicines, Inc. (Subject)
Revolution Medicines (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
12/20/2024
3:50 PM | GOLDSMITH MARK A (Reporting)
Revolution Medicines, Inc. (Issuer)
Revolution Medicines (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/18/2024
3:08 PM | GOLDSMITH MARK A (Reporting)
Revolution Medicines, Inc. (Issuer)
Revolution Medicines (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/18/2024
3:09 PM | Horn Margaret A (Reporting)
Revolution Medicines, Inc. (Issuer)
Revolution Medicines (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/18/2024
3:06 PM | Anders Jack (Reporting)
Revolution Medicines, Inc. (Issuer)
Revolution Medicines (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/18/2024
3:07 PM | Cislini Jeff (Reporting)
Revolution Medicines, Inc. (Issuer)
Revolution Medicines (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/18/2024
3:07 PM | Kelsey Stephen Michael (Reporting)
Revolution Medicines, Inc. (Issuer)
Revolution Medicines (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/16/2024
8:35 PM | GOLDSMITH MARK A (Reporting)
Revolution Medicines, Inc. (Subject)
Revolution Medicines (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
12/16/2024
7:42 PM | Kelsey Stephen Michael (Reporting)
Revolution Medicines, Inc. (Subject)
Revolution Medicines (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
12/16/2024
7:01 PM | Cislini Jeff (Reporting)
Revolution Medicines, Inc. (Subject)
Revolution Medicines (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
12/16/2024
6:39 PM | Horn Margaret A (Reporting)
Revolution Medicines, Inc. (Subject)
Revolution Medicines (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
12/16/2024
3:57 PM | Anders Jack (Reporting)
Revolution Medicines, Inc. (Subject)
Revolution Medicines (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
12/05/2024
3:18 PM | Revolution Medicines, Inc. (Filer)
Revolution Medicines (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/03/2024
8:37 PM | Revolution Medicines, Inc. (Subject)
Revolution Medicines (Subject)
| Form FWP | |
12/02/2024
4:21 PM | Revolution Medicines, Inc. (Filer)
Revolution Medicines (Filer)
| Form 424B5 | |
12/02/2024
6:30 AM | Revolution Medicines, Inc. (Filer)
Revolution Medicines (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/08/2024
3:20 PM | Cislini Jeff (Reporting)
Revolution Medicines, Inc. (Issuer)
Revolution Medicines (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
Elon’s Terrifying Warning Forces Trump To Take Action (Ad) Elon Musk has avoided two major financial crises before. He pulled Tesla and SpaceX back from the brink of collapse and built two of the most valuable companies in history.
Now, he's sounding the alarm about America's $36 trillion debt time bomb that could destroy the fabric of our society.As head of the Department of Government Efficiency (DOGE) under President Trump, Musk is exposing just how bad things are... Get your free gold guide! |
11/08/2024
9:52 AM | Revolution Medicines, Inc. (Subject)
Revolution Medicines (Subject)
WELLINGTON MANAGEMENT GROUP LLP (Filed by)
| Form SC 13G/A | |
11/06/2024
4:07 PM | Cislini Jeff (Reporting)
Revolution Medicines, Inc. (Subject)
Revolution Medicines (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
11/06/2024
3:05 PM | Revolution Medicines, Inc. (Filer)
Revolution Medicines (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/06/2024
3:10 PM | Revolution Medicines, Inc. (Filer)
Revolution Medicines (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
11/01/2024
3:42 PM | GOLDSMITH MARK A (Reporting)
Revolution Medicines, Inc. (Subject)
Revolution Medicines (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
11/01/2024
3:42 PM | GOLDSMITH MARK A (Reporting)
Revolution Medicines, Inc. (Subject)
Revolution Medicines (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
11/01/2024
3:43 PM | GOLDSMITH MARK A (Reporting)
Revolution Medicines, Inc. (Subject)
Revolution Medicines (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
10/31/2024
3:30 PM | Patel Sushil (Reporting)
Revolution Medicines, Inc. (Subject)
Revolution Medicines (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
10/25/2024
5:43 AM | Revolution Medicines, Inc. (Filer)
Revolution Medicines (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/23/2024
5:05 AM | Revolution Medicines, Inc. (Filer)
Revolution Medicines (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/16/2024
3:07 PM | Kelsey Stephen Michael (Reporting)
Revolution Medicines, Inc. (Issuer)
Revolution Medicines (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/15/2024
4:29 PM | Cislini Jeff (Reporting)
Revolution Medicines, Inc. (Issuer)
Revolution Medicines (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/15/2024
4:30 PM | Anders Jack (Reporting)
Revolution Medicines, Inc. (Issuer)
Revolution Medicines (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/15/2024
4:30 PM | GOLDSMITH MARK A (Reporting)
Revolution Medicines, Inc. (Issuer)
Revolution Medicines (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/15/2024
4:31 PM | Horn Margaret A (Reporting)
Revolution Medicines, Inc. (Issuer)
Revolution Medicines (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/15/2024
7:03 AM | Kelsey Stephen Michael (Reporting)
Revolution Medicines, Inc. (Subject)
Revolution Medicines (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
10/10/2024
3:16 PM | Revolution Medicines, Inc. (Issuer)
Revolution Medicines (Issuer)
Weber Barbara (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/08/2024
3:23 PM | Revolution Medicines, Inc. (Subject)
Revolution Medicines (Subject)
Weber Barbara (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
10/03/2024
3:33 PM | GOLDSMITH MARK A (Reporting)
Revolution Medicines, Inc. (Issuer)
Revolution Medicines (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/01/2024
3:33 PM | GOLDSMITH MARK A (Reporting)
Revolution Medicines, Inc. (Subject)
Revolution Medicines (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
09/18/2024
3:16 PM | Cislini Jeff (Reporting)
Revolution Medicines, Inc. (Issuer)
Revolution Medicines (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/18/2024
3:17 PM | Kelsey Stephen Michael (Reporting)
Revolution Medicines, Inc. (Issuer)
Revolution Medicines (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/18/2024
3:17 PM | Horn Margaret A (Reporting)
Revolution Medicines, Inc. (Issuer)
Revolution Medicines (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/18/2024
3:18 PM | GOLDSMITH MARK A (Reporting)
Revolution Medicines, Inc. (Issuer)
Revolution Medicines (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/18/2024
3:18 PM | Anders Jack (Reporting)
Revolution Medicines, Inc. (Issuer)
Revolution Medicines (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/16/2024
6:06 PM | Anders Jack (Reporting)
Revolution Medicines, Inc. (Subject)
Revolution Medicines (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
09/16/2024
5:41 PM | Kelsey Stephen Michael (Reporting)
Revolution Medicines, Inc. (Subject)
Revolution Medicines (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
09/16/2024
5:22 PM | Horn Margaret A (Reporting)
Revolution Medicines, Inc. (Subject)
Revolution Medicines (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
09/16/2024
4:37 PM | Cislini Jeff (Reporting)
Revolution Medicines, Inc. (Subject)
Revolution Medicines (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
09/16/2024
4:15 PM | GOLDSMITH MARK A (Reporting)
Revolution Medicines, Inc. (Subject)
Revolution Medicines (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
09/16/2024
4:24 PM | Anders Jack (Reporting)
Revolution Medicines, Inc. (Subject)
Revolution Medicines (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
09/13/2024
3:23 PM | Kelsey Stephen Michael (Reporting)
Revolution Medicines, Inc. (Subject)
Revolution Medicines (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
08/23/2024
3:15 PM | Revolution Medicines, Inc. (Issuer)
Revolution Medicines (Issuer)
Weber Barbara (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/15/2024
3:48 PM | Kelsey Stephen Michael (Reporting)
Revolution Medicines, Inc. (Issuer)
Revolution Medicines (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/07/2024
4:34 PM | Clyburn Frank (Reporting)
Revolution Medicines, Inc. (Issuer)
Revolution Medicines (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
08/07/2024
4:34 PM | Clyburn Frank (Reporting)
Revolution Medicines, Inc. (Issuer)
Revolution Medicines (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/07/2024
4:07 PM | Revolution Medicines, Inc. (Filer)
Revolution Medicines (Filer)
| Form 424B5 | |
08/02/2024
4:35 PM | GOLDSMITH MARK A (Reporting)
Revolution Medicines, Inc. (Issuer)
Revolution Medicines (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/01/2024
3:29 PM | GOLDSMITH MARK A (Reporting)
Revolution Medicines, Inc. (Subject)
Revolution Medicines (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
07/16/2024
4:05 PM | GOLDSMITH MARK A (Reporting)
Revolution Medicines, Inc. (Issuer)
Revolution Medicines (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/15/2024
3:27 PM | Kelsey Stephen Michael (Reporting)
Revolution Medicines, Inc. (Subject)
Revolution Medicines (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
07/15/2024
7:03 AM | Revolution Medicines, Inc. (Filer)
Revolution Medicines (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/12/2024
3:35 PM | GOLDSMITH MARK A (Reporting)
Revolution Medicines, Inc. (Subject)
Revolution Medicines (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
07/12/2024
3:36 PM | GOLDSMITH MARK A (Reporting)
Revolution Medicines, Inc. (Subject)
Revolution Medicines (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
07/12/2024
3:36 PM | GOLDSMITH MARK A (Reporting)
Revolution Medicines, Inc. (Subject)
Revolution Medicines (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
07/10/2024
3:36 PM | Patel Sushil (Reporting)
Revolution Medicines, Inc. (Issuer)
Revolution Medicines (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/10/2024
3:36 PM | Cislini Jeff (Reporting)
Revolution Medicines, Inc. (Issuer)
Revolution Medicines (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/09/2024
3:19 PM | Cislini Jeff (Reporting)
Revolution Medicines, Inc. (Subject)
Revolution Medicines (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
07/09/2024
3:19 PM | Patel Sushil (Reporting)
Revolution Medicines, Inc. (Subject)
Revolution Medicines (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
06/28/2024
4:05 PM | Horning Sandra (Reporting)
Revolution Medicines, Inc. (Issuer)
Revolution Medicines (Issuer)
| Form 4/A | |
Think NVDA’s run was epic? You ain’t seen nothin’ yet (Ad) Ask most investors and they’ll probably tell you Nvidia is the undisputed AI stock of the decade.
In 2023, it surged 239%. And in 2024, it soared another 171% on the year…
But what if I told you there was a way to target those types of “peak Nvidia” profit opportunities in 24 hours or less? Click to find out what Nvidia’s CEO might reveal… and how Sykes is preparing to ride the wave. |
06/28/2024
4:06 PM | Patel Sushil (Reporting)
Revolution Medicines, Inc. (Issuer)
Revolution Medicines (Issuer)
| Form 4/A | |
06/28/2024
4:06 PM | Borisy Alexis (Reporting)
Revolution Medicines, Inc. (Issuer)
Revolution Medicines (Issuer)
| Form 4/A | |
06/28/2024
4:07 PM | Kim Lorence H. (Reporting)
Revolution Medicines, Inc. (Issuer)
Revolution Medicines (Issuer)
| Form 4/A | |
06/28/2024
4:07 PM | Revolution Medicines, Inc. (Issuer)
Revolution Medicines (Issuer)
Weber Barbara (Reporting)
| Form 4/A | |
06/28/2024
4:08 PM | Borellini Flavia (Reporting)
Revolution Medicines, Inc. (Issuer)
Revolution Medicines (Issuer)
| Form 4/A | |
06/28/2024
4:09 PM | ANDERSON ELIZABETH M (Reporting)
Revolution Medicines, Inc. (Issuer)
Revolution Medicines (Issuer)
| Form 4/A | |
06/27/2024
5:48 PM | Cislini Jeff (Reporting)
Revolution Medicines, Inc. (Issuer)
Revolution Medicines (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/26/2024
3:20 PM | Cislini Jeff (Reporting)
Revolution Medicines, Inc. (Subject)
Revolution Medicines (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
06/24/2024
3:20 PM | ANDERSON ELIZABETH M (Reporting)
Revolution Medicines, Inc. (Issuer)
Revolution Medicines (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
Buy RVMDW Stock Free RVMDW Stock Alerts